Xiaochun Zhang
Plus aucun poste en cours
Fortune : 165 900 $ au 31/05/2024
Profil
Xiaochun Zhang worked as a General Manager for Dragon Pharmaceutical, Inc., as a Deputy General Manager for Aurobindo Bio Pharma Co. Ltd.
and Zhangjiakou Pharmaceutical Co., and as a General Manager for GIST-Biocades Pharmaceutical Co. Ltd.
Mr. Zhang obtained an undergraduate degree from Hebei University of Science & Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TANTECH HOLDINGS LTD.
5,13% | 25/07/2023 | 210 000 ( 5,13% ) | 165 900 $ | 31/05/2024 |
Anciens postes connus de Xiaochun Zhang
| Sociétés | Poste | Fin |
|---|---|---|
| GIST-Biocades Pharmaceutical Co. Ltd. | Corporate Officer/Principal | - |
| Aurobindo Bio Pharma Co. Ltd. | Corporate Officer/Principal | - |
| Zhangjiakou Pharmaceutical Co. | Corporate Officer/Principal | - |
Dragon Pharmaceutical, Inc.
 Dragon Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - |
Formation de Xiaochun Zhang
| Hebei University of Science & Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Dragon Pharmaceutical, Inc.
Dragon Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada. | Health Technology |
| Aurobindo Bio Pharma Co. Ltd. | |
| Zhangjiakou Pharmaceutical Co. | |
| GIST-Biocades Pharmaceutical Co. Ltd. |
